Everest Organics

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE334C01029
  • NSEID:
  • BSEID: 524790
INR
441.00
29.3 (7.12%)
BSENSE

Dec 05

BSE+NSE Vol: 2.18 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Trident Lifeline
Medico Remedies
Everest Organics
Haleos Labs Limi
Bafna Pharma.
Albert David
Nectar Lifesci.
Kerala Ayurveda
Solara Active PP
Amanta Healthcar
Infinium Pharma
Why is Everest Organics Ltd ?
1
Weak Long Term Fundamental Strength with a -9.29% CAGR growth in Operating Profits over the last 5 years
  • Low ability to service debt as the company has a high Debt to EBITDA ratio of 6.46 times
  • The company has been able to generate a Return on Equity (avg) of 5.58% signifying low profitability per unit of shareholders funds
2
With a growth in Operating Profit of 8.62%, the company declared Very Positive results in Sep 25
  • The company has declared positive results for the last 4 consecutive quarters
  • PAT(Latest six months) At Rs 2.57 cr has Grown at 148.04%
  • OPERATING PROFIT TO INTEREST(Q) Highest at 4.17 times
  • NET SALES(Latest six months) At Rs 104.81 cr has Grown at 37.01%
3
With ROCE of 9.1, it has a Expensive valuation with a 3.8 Enterprise value to Capital Employed
  • The stock is trading at a discount compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 207.96%, its profits have risen by 225.6% ; the PEG ratio of the company is 0.3
4
Reducing Promoter Confidence
  • Promoters have decreased their stake in the company by -1.35% over the previous quarter and currently hold 59.64% of the company
  • Promoters decreasing their stake may signify reduced confidence in the future of the business
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Everest Organics should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Everest Organics for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Everest Organics
207.96%
3.54
58.81%
Sensex
4.74%
0.40
11.83%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
1.52%
EBIT Growth (5y)
-9.29%
EBIT to Interest (avg)
1.05
Debt to EBITDA (avg)
15.01
Net Debt to Equity (avg)
0.67
Sales to Capital Employed (avg)
1.89
Tax Ratio
4.76%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.02%
ROCE (avg)
1.12%
ROE (avg)
5.58%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
61
Industry P/E
34
Price to Book Value
5.61
EV to EBIT
41.56
EV to EBITDA
26.74
EV to Capital Employed
3.77
EV to Sales
2.42
PEG Ratio
0.30
Dividend Yield
NA
ROCE (Latest)
9.06%
ROE (Latest)
9.13%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

23What is working for the Company
PAT(Latest six months)

At Rs 2.57 cr has Grown at 148.04%

OPERATING PROFIT TO INTEREST(Q)

Highest at 4.17 times

NET SALES(Latest six months)

At Rs 104.81 cr has Grown at 37.01%

ROCE(HY)

Highest at 9.86%

DEBT-EQUITY RATIO(HY)

Lowest at 0.68 times

PBDIT(Q)

Highest at Rs 5.13 cr.

OPERATING PROFIT TO NET SALES(Q)

Highest at 10.06%

PBT LESS OI(Q)

Highest at Rs 2.38 cr.

-1What is not working for the Company
DEBTORS TURNOVER RATIO(HY)

Lowest at 1.63 times

Loading Valuation Snapshot...
Here's what is working for Everest Organics
Profit After Tax (PAT) - Latest six months
At Rs 2.57 cr has Grown at 148.04%
Year on Year (YoY)
MOJO Watch
PAT trend is very positive

PAT (Rs Cr)

Operating Profit to Interest - Quarterly
Highest at 4.17 times and Grown
each quarter in the last five quarters
MOJO Watch
The company's ability to manage interest payments is improving

Operating Profit to Interest

Net Sales - Latest six months
At Rs 104.81 cr has Grown at 37.01%
Year on Year (YoY)
MOJO Watch
Near term sales trend is positive

Net Sales (Rs Cr)

Profit After Tax (PAT) - Latest six months
Higher at Rs 2.57 cr
than preceding 12 month period ended Sep 2025 of Rs -1.30 cr
MOJO Watch
In the half year the company has already crossed PAT of the previous twelve months

PAT (Rs Cr)

Operating Profit (PBDIT) - Quarterly
Highest at Rs 5.13 cr.
in the last five quarters
MOJO Watch
Near term Operating Profit trend is positive

Operating Profit (Rs Cr)

Operating Profit Margin - Quarterly
Highest at 10.06%
in the last five quarters
MOJO Watch
Company's efficiency has improved

Operating Profit to Sales

Profit Before Tax less Other Income (PBT) - Quarterly
Highest at Rs 2.38 cr.
in the last five quarters
MOJO Watch
Near term PBT trend is positive

PBT less Other Income (Rs Cr)

Debt-Equity Ratio - Half Yearly
Lowest at 0.68 times
in the last five half yearly periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Here's what is not working for Everest Organics
Debtors Turnover Ratio- Half Yearly
Lowest at 1.63 times
in the last five half yearly periods
MOJO Watch
Company's pace of settling its Debtors has slowed

Debtors Turnover Ratio